Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
57.18
+0.27 (0.47%)
At close: May 29, 2026, 4:00 PM EDT
57.17
-0.01 (-0.02%)
After-hours: May 29, 2026, 7:59 PM EDT
BMY Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 48,482 | 48,194 | 48,300 | 45,006 | 46,159 | 46,385 | |
Revenue Growth (YoY) | 1.78% | -0.22% | 7.32% | -2.50% | -0.49% | 9.10% |
Cost of Revenue | 14,325 | 13,936 | 13,968 | 10,693 | 10,137 | 9,940 |
Gross Profit | 34,157 | 34,258 | 34,332 | 34,313 | 36,022 | 36,445 |
Selling, General & Admin | 7,300 | 7,267 | 8,414 | 7,772 | 7,814 | 7,690 |
Depreciation & Amortization Expenses | 2,924 | 3,317 | 8,872 | 9,047 | 9,595 | 10,023 |
Research & Development | 13,971 | 13,672 | 24,532 | 10,212 | 10,324 | 11,354 |
Total Operating Expenses | 24,195 | 24,256 | 41,818 | 27,031 | 27,733 | 29,067 |
Operating Income | 9,962 | 10,002 | -7,486 | 7,282 | 8,289 | 7,378 |
Interest Income | 148 | - | - | - | - | - |
Interest Expense | -432 | - | - | - | - | - |
Other Non-Operating Income (Expense) | 23 | -674 | -893 | 1,158 | -576 | 720 |
Total Non-Operating Income (Expense) | -261 | -674 | -893 | 1,158 | -576 | 720 |
Pretax Income | 9,597 | 9,328 | -8,379 | 8,440 | 7,713 | 8,098 |
Provision for Income Taxes | 2,324 | 2,272 | 554 | 400 | 1,368 | 1,084 |
Net Income | 7,270 | 7,055 | -8,933 | 8,040 | 6,345 | 7,014 |
Minority Interest in Earnings | 1 | - | - | - | - | - |
Net Income to Common | 7,270 | 7,055 | -8,933 | 8,040 | 6,345 | 7,014 |
Net Income Growth | 33.86% | - | - | 26.71% | -9.54% | - |
Shares Outstanding (Basic) | 2,036 | 2,034 | 2,027 | 2,069 | 2,130 | 2,221 |
Shares Outstanding (Diluted) | 2,041 | 2,039 | 2,027 | 2,078 | 2,146 | 2,245 |
Shares Change (YoY) | 0.34% | 0.59% | -2.45% | -3.17% | -4.41% | -0.58% |
EPS (Basic) | 3.56 | 3.47 | -4.41 | 3.88 | 2.97 | 3.15 |
EPS (Diluted) | 3.56 | 3.46 | -4.41 | 3.86 | 2.95 | 3.12 |
EPS Growth | 33.33% | - | - | 30.85% | -5.45% | - |
Shares Outstanding | 2,042 | 2,036 | 2,029 | 2,021 | 2,098 | 2,176 |
Free Cash Flow | 11,908 | 12,845 | 13,942 | 12,651 | 11,948 | 15,234 |
Free Cash Flow Growth | -7.29% | -7.87% | 10.21% | 5.88% | -21.57% | 14.55% |
Free Cash Flow Per Share | 5.83 | 6.30 | 6.88 | 6.09 | 5.57 | 6.79 |
Dividends Per Share | 2.500 | 2.490 | 2.420 | 2.310 | 2.190 | 2.010 |
Dividend Growth | 0.40% | 2.89% | 4.76% | 5.48% | 8.96% | 9.24% |
Gross Margin | 70.45% | 71.08% | 71.08% | 76.24% | 78.04% | 78.57% |
Operating Margin | 20.55% | 20.75% | -15.50% | 16.18% | 17.96% | 15.91% |
Profit Margin | 15.00% | 14.64% | -18.49% | 17.86% | 13.75% | 15.12% |
FCF Margin | 24.56% | 26.65% | 28.87% | 28.11% | 25.88% | 32.84% |
EBITDA | 13,555 | 14,013 | 2,114 | 17,042 | 18,565 | 18,064 |
EBITDA Margin | 27.96% | 29.08% | 4.38% | 37.87% | 40.22% | 38.94% |
EBIT | 9,962 | 10,002 | -7,486 | 7,282 | 8,289 | 7,378 |
EBIT Margin | 20.55% | 20.75% | -15.50% | 16.18% | 17.96% | 15.91% |
Effective Tax Rate | 24.22% | 24.36% | -6.61% | 4.74% | 17.74% | 13.39% |